Home / Diagnostics and Treatment
Home / Neurology and Mental Health

Earwax Biomarkers Could Enable Early Parkinson’s Screening

Earwax Biomarkers Could Enable Early Parkinson’s Screening

AI‑Enhanced Earwax Analysis for Parkinson’s Detection

New research from Zhejiang University shows that volatile organic compounds (VOCs) in earwax could serve as reliable biomarkers for Parkinson’s disease.

🧪 Study Outline

  • Swabs collected from 209 individuals (108 diagnosed with Parkinson’s, 101 controls).
  • Analyzed by gas chromatography–mass spectrometry and surface‑acoustic‑wave sensors.
  • Identified four key VOCs—ethylbenzene, 4‑ethyltoluene, pentanal, 2‑pentadecyl‑1,3‑dioxolane.

👍 Key Results

An AI‑powered olfactory system achieved 94–94.4% accuracy and AUC ~0.98 in distinguishing Parkinson’s individuals.

🌍 Significance

This is a noninvasive, low‑cost method, ideal for early screening. Earwax is more stable than skin sebum, making it reliable for testing.

📈 Next Steps

Further validation across multiple centers and demographics is required before clinical deployment.

More Articles